Urine Methylmalonic Acid (MMA) Testing

Urine Methylmalonic Acid (MMA) Testing

Urine methylmalonic acid measurement is a highly sensitive metabolic marker for vitamin B12 deficiency and inherited disorders of B12 metabolism.

Key Points:

  • Gold standard for functional B12 deficiency assessment
  • Essential for diagnosing inherited metabolic disorders
  • More sensitive than serum B12 levels
  • Critical for newborn screening programs
  • Valuable for monitoring treatment response

Clinical Applications

Primary Indications:

  • Suspected vitamin B12 deficiency
  • Unexplained metabolic acidosis
  • Developmental delay
  • Failure to thrive
  • Seizures
  • Hypotonia
  • Lethargy
  • Recurrent vomiting

Screening Applications:

  • Newborn metabolic screening
  • Family history of inherited metabolic disorders
  • High-risk population screening
  • Monitoring known cases

Sample Collection and Handling

Collection Requirements:

  • 24-hour urine collection preferred
  • Random urine acceptable for screening
  • First morning void recommended for random samples
  • Sterile container required
  • Refrigerate during collection

Special Considerations:

  • Avoid contamination
  • Protected from light
  • Transport on ice
  • Process within 24 hours
  • Document collection time and volume
  • Note recent medications

Reference Values and Ranges

Age-Specific Reference Ranges:

Newborns (0-30 days): 0-10 mmol/mol creatinine

Infants (1-12 months): 0-8 mmol/mol creatinine

Children (1-18 years): 0-5 mmol/mol creatinine

Critical Values:

  • Mild elevation: 5-20 mmol/mol creatinine
  • Moderate elevation: 20-100 mmol/mol creatinine
  • Severe elevation: >100 mmol/mol creatinine
  • Critical alert value: >200 mmol/mol creatinine

Result Interpretation

Elevated MMA Causes:

  • Vitamin B12 deficiency
  • Methylmalonic acidemia
  • Combined methylmalonic acidemia and homocystinuria
  • Dehydration
  • Renal insufficiency
  • Bacterial overgrowth

Clinical Correlation:

  • Consider serum B12 levels
  • Assess homocysteine levels
  • Review dietary history
  • Evaluate maternal B12 status
  • Consider genetic testing
  • Monitor trending values

Associated Disorders and Conditions

Inherited Metabolic Disorders:

  • Methylmalonic acidemia (MMA)
    • MUT gene defects
    • MMAA gene defects
    • MMAB gene defects
    • MMADHC gene defects
  • Combined disorders
    • Cobalamin C deficiency
    • Cobalamin D deficiency
    • Cobalamin F deficiency

Treatment Monitoring:

  • Response to B12 supplementation
  • Dietary protein restriction effectiveness
  • Metabolic crisis prevention
  • Long-term management success


Further Reading
Powered by Blogger.